Summary
54 / 100 · Bulios Score
What speaks for it
- Revenue grew by 15% a year over the last 3 years.
- It earns 10 INR a year on every 100 INR of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 4.9 years of operating profit.
- Earnings per share fell by 12% a year over the last 3 years.
- Out of every 100 INR of revenue, only 0.9 INR is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 20.2 INR for 1 INR of yearly profit. Over the last five years it was 14.2 INR on average.
Valuation in detailIs it growing?
SlowlyRevenue (INR)
Diluted EPS (INR)
Revenue grew by 49% a year over 5 years. Over the last 3 years it grew by 15% a year. Earnings per share fell by 12% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 INR of revenue goes
- Cost of sales 87 INR
- Sales and administration 9.8 INR
- Taxes and other 2.2 INR
- Net profit 0.9 INR
Net profit, industry median (Chemicals - Specialty) 6.1 INR
Out of every 100 INR of revenue, 0.9 INR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenIts debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail